Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Summary of Research: Cognition and Employment Status of People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two-Year CLARIFY-MS Study.
IL-6 Receptor Blockade as Rescue Therapy in Acute Attacks of MOGAD and AQP4+NMOSD.
Short protocol MRI Brain in clinical evaluation of suspected stroke, a time saver on the timetable?
Effects of binaural beats on acute stress recovery and autonomic regulation in multiple sclerosis: a pilot double-blind randomized controlled trial.
Adjunctive Dulaglutide in Relapsing-Remitting Multiple Sclerosis: A Randomized Open-Label Proof-of-Concept Trial.
From perimenopause to neuroinflammation: Rethinking a case of late-onset mania.
Efficacy and safety of ofatumumab in participants with relapsing multiple sclerosis and breakthrough disease on oral fingolimod or fumarates: results from the ARTIOS study.
Blood cytotoxic natural killer-like CD8 + CD94+ T cells migrate to the brain and predict multiple sclerosis severity.
Folate and global health review series, part 4: syntheses on folate and autoimmune diseases and skeletal outcomes.
Adjunctive gypenosides for acute optic neuritis: A prematurely terminated randomized, double-blind, placebo-controlled pilot trial in a cohort with frequent AQP4-IgG positivity.
Thymus-derived myeloid programs track microglial tolerance states across human cohorts.
Serum neurofilament light chain in multiple sclerosis: from biological signal to clinically informed decision-making.
Lesion burden determines the incremental diagnostic value of intrathecal IgG oligoclonal bands synthesis in multiple sclerosis.
Perspectives of participating neurologists and study nurses - Mixed-methods process evaluation of a web-based program for relapse management in multiple sclerosis (POWER@M2).
Colorectal cancer screening in individuals with multiple sclerosis: A mixed-methods study.
Cyberchondria severity in multiple sclerosis: the role of sociodemographic and clinical factors.
Crosstalk Between Oligodendrocyte Lineage Cells and CNS-Resident and Peripheral Immune Cells Governs Demyelination and Remyelination in Multiple Sclerosis.
Kupffer cells are key mediators of antigen-specific immune tolerance by peptide-coupled red blood cells.
Regulatory B cells in the central nervous system: From immune regulation to neuroprotection.
Synthesis strategies of gold nanoclusters and their application in anti-inflammatory therapy.
Clinicoradiologic profile of neuromyelitis optica spectrum disorder in a Kashmiri cohort: a prospective observational cohort study.
The meningeal lymphatic vessel-peripheral immune axis: a novel therapeutic target in neurodegenerative diseases.
Web of Science Bibliometrics Analysis of Magnetic Resonance Imaging Research Advances in Multiple Sclerosis.
Effectiveness of Blood Flow Restriction Training in Neurological Rehabilitation: A Systematic Review and Meta-analysis.
When psychological signals meet neurological disability: An explainable XGBoost study of dissociative symptoms in people with multiple sclerosis.
Pages
« first
‹ previous
…
861
862
863
864
865
866
867
868
869
…
next ›
last »